An upstart protein degradation contender adds Merck KGaA and Bristol Myers to its list of Big Pharma backers

An upstart protein degradation contender adds Merck KGaA and Bristol Myers to its list of Big Pharma backers
4 May 2022
Endpoints News – View full story